Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Immucell Corp. (ICCC)
NASDAQ:ICCC
Holding ICCC?
Track your performance easily
ICCC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.34 - $5.82
Previous Close$4.41
Volume24.46K
Average Volume (3M)19.10K
Market Cap
$39.30M
Enterprise Value$54.83M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$15.53M
Price to Earnings (P/E)―
Beta0.50
Next Earnings
Feb 25, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.48
Shares Outstanding8,911,589
10 Day Avg. Volume333,566
30 Day Avg. Volume19,099
Standard Deviation0.13
R-Squared0.06
Alpha-0.00239
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)1.49
Price to Sales (P/S)1.65
Price to Cash Flow (P/CF)-15.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.30
Enterprise Value/Gross Profit14.17
Enterprise Value/Ebitda-114.25
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Immucell News
PremiumCompany Announcements
Immucell Announces Leadership Transition and Strategic Plans
PremiumCompany Announcements
ImmuCell Reports Strong Sales Growth in Q3 2024
Ownership Overview
1.55%
Insiders
3.60% Mutual Funds
2.63% Other Institutional Investors
89.41% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ICCC FAQ
What was Immucell Corp.’s price range in the past 12 months?
Immucell Corp. lowest stock price was $3.34 and its highest was $5.82 in the past 12 months.
What is Immucell Corp.’s market cap?
Currently, no data Available
When is Immucell Corp.’s upcoming earnings report date?
Immucell Corp.’s upcoming earnings report date is Feb 25, 2025 which is in 64 days.
How were Immucell Corp.’s earnings last quarter?
Immucell Corp. released its earnings results on Nov 13, 2024. The company reported -$0.086 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.086.
Is Immucell Corp. overvalued?
According to Wall Street analysts Immucell Corp.’s price is currently Overvalued.
Does Immucell Corp. pay dividends?
Immucell Corp. does not currently pay dividends.
What is Immucell Corp.’s EPS estimate?
Immucell Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Immucell Corp. have?
Immucell Corp. has 8,911,589 shares outstanding.
What happened to Immucell Corp.’s price movement after its last earnings report?
Immucell Corp. reported an EPS of -$0.086 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.983%.
Which hedge fund is a major shareholder of Immucell Corp.?
Currently, no hedge funds are holding shares in ICCC
---
Immucell Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-7.93%
12-Months-Change
Fundamentals
Return on Equity
-14.54%
Trailing 12-Months
Asset Growth
-0.22%
Trailing 12-Months
Company Description
Immucell Corp.
ImmuCell Corp. engages in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include first defense for scours, California mastitis test kit and purified nisin intramammary treatment for mastitis. The company was founded in 1982 and is headquartered in Portland, ME.
---
ICCC Company Deck
---
ICCC Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted improved sales and EBITDA, indicating strong demand for the First Defense product line, and an improved cash position. However, challenges remain with gross margins, production contamination, regulatory delays, and increased cost of goods sold.Read More>---
Technical Analysis
---